/category/analysis/page/86/
Daily Market Analysis Market Focus U.S. markets drift slightly higher as investors assess economic reports and a resurgence of coronavirus cases in Europe. Economic data from most of euro- area seem to worsen than expected, except the U.K. Europe is …
Daily Market Analysis Market Focus Stocks climbed as gains in giant technology companies drove the Nasdaq 100 to a record, tempering concern that a recovery from the pandemic-induced recession will need more time. Treasuries rose. The rally in heavyweights such …
Daily Market Analysis Market Focus Stocks are slightly higher after closing at a record for the first time since COVID-19 started amid a rebound in giant technology companies. Major indexes advance as investors are waiting for the latest stimulus plan …
Daily Market Analysis Market Focus Major U.S. indexes climb, buoyed by Chinese stimulus overnight, as of writing. The S&P 500 aims at its before the pandemic closing- record; the Nasdaq outperforms as a jump in several technological companies. In the …
Daily Market Analysis Market Focus US equity market was mixed as stimulus negotiations linger. The White House and the Treasury is $1 trillion away from reaching a deal, “we have made clear to the administration that we are willing …
Daily Market Analysis Market Focus An American biotechnological company, Moderna Inc. reached an unprecedented deal of $1.5 billion with the Trump administration to supply 100 million does of its experimental vaccine for COVID-19. Under the deal, Moderna Inc. will provide …
Daily Market Analysis Market Focus President Donald Trump is considering a tax cut on capital gains and American hospitalization for coronavirus fell to their lowest in a month. “We’re considering a capital tax cut, which could create a lot more …
Daily Market Analysis Market Focus U.S. market was fluctuating with mixed information. Dow Jones gained as investors considered more earning results and potential outcomes for coronavirus- related stimulus. Despite of failing to make progress on a new coronavirus stimulus plan …
Daily Market Analysis Market Focus US and European equity edged higher amid encouraging news on the vaccine front. Novavax joins the ranks of AstraZeneca Plc, Moderna Inc., Pfizer Inc. and BioNTech SE which has all reported Phase 1 results …
Daily Market Analysis Market Focus US equity advanced as positive economic data outweighed pandemic pessimism. The White House is concerned about the economic impact of the benefits having expired on Friday, and was said to consider acting on its …
Education
Risk Warning: Trading CFDs carries a high level of risk and may not be suitable for all investors. Leverage in CFD trading can magnify gains and losses, potentially exceeding your original capital. It’s crucial to fully understand and acknowledge the associated risks before trading CFDs. Consider your financial situation, investment goals, and risk tolerance before making trading decisions. Past performance is not indicative of future results. Refer to our legal documents for a comprehensive understanding of CFD trading risks.
The information on this website is general and doesn’t account for your individual goals, financial situation, or needs. VT Markets cannot be held liable for the relevance, accuracy, timeliness, or completeness of any website information.
Our services and information on this website are not provided to residents of certain countries, including the United States, Singapore, Russia, and jurisdictions listed on the FATF and global sanctions lists. They are not intended for distribution or use in any location where such distribution or use would contravene local law or regulation.
VT Markets is a brand name with multiple entities authorised and registered in various jurisdictions.
· VT Global Pty Ltd is authorised and regulated by the Australian Securities & Investments Commission (ASIC) under licence number 516246.
· VT Global is not an issuer or market maker of derivatives and is only allowed to provide services to wholesale clients.
· VT Markets (Pty) Ltd is an authorised Financial Service Provider (FSP) registered and regulated by the Financial Sector Conduct Authority (FSCA) of South Africa under license number 50865.
· VT Markets Limited is an investment dealer authorised and regulated by the Mauritius Financial Services Commission (FSC) under license number GB23202269.
Copyright © 2025 VT Markets.